Literature DB >> 35080426

Adenovirus-α-Defensin Complexes Induce NLRP3-Associated Maturation of Human Phagocytes via Toll-Like Receptor 4 Engagement.

Karsten Eichholz1, Tuan Hiep Tran1, Coraline Chéneau1, Thi Thu Phuong Tran1, Océane Paris1, Martine Pugniere2, Eric J Kremer1.   

Abstract

Intramuscular delivery of human adenovirus (HAdV)-based vaccines leads to rapid recruitment of neutrophils, which then release antimicrobial peptides/proteins (AMPs). How these AMPs influence vaccine efficacy over the subsequent 24 h is poorly understood. In this study, we asked if human neutrophil protein 1 (HNP-1), an α-defensin that influences direct and indirect innate immune responses to a range of pathogens, impacts the response of human phagocytes to three HAdV species/types (HAdV-C5, -D26, -B35). We show that HNP-1 binds to the capsids and redirects HAdV-C5, -D26, and -B35 to Toll-like receptor 4 (TLR4), which leads to internalization, an NLRP3-mediated inflammasome response, and interleukin 1 beta (IL-1β) release. Surprisingly, IL-1β release was not associated with notable disruption of plasma membrane integrity. These data further our understanding of HAdV vaccine immunogenicity and may provide pathways to extend the efficacy. IMPORTANCE This study examines the interactions between danger-associated molecular patterns and human adenoviruses, and their impact on vaccines. HAdVs and HNP-1 can interact, and these interactions will modify the response of antigen-presenting cells, which will influence vaccine efficacy.

Entities:  

Keywords:  Toll-like receptors; adenoviruses; antimicrobial peptides; innate immunity; phagocytes

Mesh:

Substances:

Year:  2022        PMID: 35080426      PMCID: PMC8941863          DOI: 10.1128/jvi.01850-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  69 in total

1.  CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.

Authors:  Ivan Zanoni; Renato Ostuni; Lorri R Marek; Simona Barresi; Roman Barbalat; Gregory M Barton; Francesca Granucci; Jonathan C Kagan
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.

Authors:  E J Kremer; S Boutin; M Chillon; O Danos
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

Review 4.  The expanding scope of antimicrobial peptide structures and their modes of action.

Authors:  Leonard T Nguyen; Evan F Haney; Hans J Vogel
Journal:  Trends Biotechnol       Date:  2011-06-15       Impact factor: 19.536

5.  Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils.

Authors:  O Chertov; D F Michiel; L Xu; J M Wang; K Tani; W J Murphy; D L Longo; D D Taub; J J Oppenheim
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

6.  CD46 is a cellular receptor for group B adenoviruses.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; André Lieber
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

7.  Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91.

Authors:  Pietro Presicce; Stefania Giannelli; Adriano Taddeo; Maria Luisa Villa; Silvia Della Bella
Journal:  J Leukoc Biol       Date:  2009-10       Impact factor: 4.962

8.  DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages.

Authors:  Ke Yang; Xinhe Liu; Yan Liu; Xinqiong Wang; Lijuan Cao; Xiaojie Zhang; Chundi Xu; Weifeng Shen; Tong Zhou
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

Review 9.  The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts.

Authors:  Nicolau B da Cunha; Nicole B Cobacho; Juliane F C Viana; Loiane A Lima; Kamila B O Sampaio; Stephan S M Dohms; Arthur C R Ferreira; César de la Fuente-Núñez; Fabrício F Costa; Octávio L Franco; Simoni C Dias
Journal:  Drug Discov Today       Date:  2016-11-23       Impact factor: 7.851

View more
  1 in total

1.  Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications.

Authors:  Qiwei Zhang; Yiqiang Li; Pascal Fender; Bin Yu; Liqiang Feng; Ling Chen; Xianghui Yu
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.